Clinical Trial Update: Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing everolimus-eluting PROMUS Element stents with biolimus A9-eluting NOBORI stents for long coronary lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• NOBORI Biolimus A9-Eluting Stent (Biolimus A9-eluting stent)
• PROMUS Element Everolimus-Eluting Coronary Stent System (everolimus-eluting coronary stent system)

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED